These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6815051)

  • 21. [Cardiotoxic side effects of adriamycin].
    Brockmann B; Matthias M
    Z Arztl Fortbild (Jena); 1983; 77(5):209-11. PubMed ID: 6858220
    [No Abstract]   [Full Text] [Related]  

  • 22. [The cardiotoxicity of anticancer agents].
    Wakasugi S
    Ryoikibetsu Shokogun Shirizu; 1996; (14):83-7. PubMed ID: 9047803
    [No Abstract]   [Full Text] [Related]  

  • 23. Initial congestive heart failure, six to ten years after doxorubicin chemotherapy for childhood cancer.
    Goorin AM; Chauvenet AR; Perez-Atayde AR; Cruz J; McKone R; Lipshultz SE
    J Pediatr; 1990 Jan; 116(1):144-7. PubMed ID: 2295956
    [No Abstract]   [Full Text] [Related]  

  • 24. Etiology and management of doxorubicin cardiotoxicity.
    Porembka DT; Lowder JN; Orlowski JP; Bastulli J; Lockrem J
    Crit Care Med; 1989 Jun; 17(6):569-72. PubMed ID: 2656100
    [No Abstract]   [Full Text] [Related]  

  • 25. Doxorubicin cardiomyopathy.
    Sanyal SK; Johnson WW
    Ann Intern Med; 1978 Jul; 89(1):136-7. PubMed ID: 666159
    [No Abstract]   [Full Text] [Related]  

  • 26. Doxorubicin (adriamycin) cardiomyopathy.
    Saltiel E; McGuire W
    West J Med; 1983 Sep; 139(3):332-41. PubMed ID: 6356608
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Daunomycin-and adriamycin-induced cardiomyopathy--relationship between dosage of drugs and histopathological findings (author's transl)].
    Yamaguchi H; Toyota S; Takahara O; Ichimaru M
    Rinsho Ketsueki; 1978 Aug; 19(8):1041-50. PubMed ID: 713049
    [No Abstract]   [Full Text] [Related]  

  • 28. The role of iron in doxorubicin-induced cardiomyopathy.
    Myers C
    Semin Oncol; 1998 Aug; 25(4 Suppl 10):10-4. PubMed ID: 9768818
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Doxorubicin cardiotoxicity.
    Unverferth DV; Magorien RD; Leier CV; Balcerzak SP
    Cancer Treat Rev; 1982 Jun; 9(2):149-64. PubMed ID: 6751530
    [No Abstract]   [Full Text] [Related]  

  • 30. Anthracycline antibiotics as cellular disruptors: insights into anthracycline-induced cardiomyopathy.
    Lewis W; Amelar SE; Puszkin S
    Mt Sinai J Med; 1984 Jun; 51(3):246-53. PubMed ID: 6205261
    [No Abstract]   [Full Text] [Related]  

  • 31. Efficacy and cost of cardiac monitoring in patients receiving doxorubicin.
    Bristow MR; Lopez MB; Mason JW; Billingham ME; Winchester MA
    Cancer; 1982 Jul; 50(1):32-41. PubMed ID: 7083125
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Monitoring cardiotoxicity during antineoplastic chemotherapy].
    Jurga L; Ponist J; Jonás P; Berc A; Misurová E
    Cesk Radiol; 1987 Jan; 41(1):28-37. PubMed ID: 3815581
    [No Abstract]   [Full Text] [Related]  

  • 33. [Echocardiography with angiotensin administration in the diagnosis of adriamycin-induced cardiomyopathy].
    Göldel N; Autenrieth G; Werdan K; Knesewitsch P; Wilmanns W
    Z Kardiol; 1989 May; 78(5):320-7. PubMed ID: 2735093
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Diagnosis of adriamycin myocardiopathy using echocardiography].
    Harpf H; Lehnert M; Tschech G
    Acta Med Austriaca Suppl; 1979; 6():341-3. PubMed ID: 299226
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Doxorubicin cardiomyopathy in children with left-sided Wilms tumor.
    Pinkel D; Camitta B; Kun L; Howarth C; Tang T
    Med Pediatr Oncol; 1982; 10(5):483-8. PubMed ID: 6292680
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adriamycin cardiotoxicity in man.
    Rinehart JJ; Lewis RP; Balcerzak SP
    Ann Intern Med; 1974 Oct; 81(4):475-8. PubMed ID: 4277990
    [No Abstract]   [Full Text] [Related]  

  • 37. An Upgrade on the Rabbit Model of Anthracycline-Induced Cardiomyopathy: Shorter Protocol, Reduced Mortality, and Higher Incidence of Overt Dilated Cardiomyopathy.
    Talavera J; Giraldo A; Fernández-Del-Palacio MJ; García-Nicolás O; Seva J; Brooks G; Moraleda JM
    Biomed Res Int; 2015; 2015():465342. PubMed ID: 26788502
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Cardiomyopathy as a severe, reversible side effect of doxorubicin (adriamycin)].
    Gerretsen M; Westerhof PW; Pinedo HM
    Ned Tijdschr Geneeskd; 1978 Jul; 122(30):1096-8. PubMed ID: 683357
    [No Abstract]   [Full Text] [Related]  

  • 39. Pathologic quiz case: congestive heart failure in a 25-year-old woman.
    Wagner MS; Husain AN
    Arch Pathol Lab Med; 2000 Sep; 124(9):1395-6. PubMed ID: 10975955
    [No Abstract]   [Full Text] [Related]  

  • 40. [Doxorubicin-induced cardiomyopathy: hemodynamic studies for evaluating the limit of therapeutic risk].
    Lenzhofer R; Magometschnigg D
    Z Kardiol; 1983 May; 72(5):297-303. PubMed ID: 6880337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.